Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 66.61%-17.98M | 80.04%-10.34M | 27.44%-165.75M | -47.60%-33.15M | 19.14%-26.97M | 18.89%-53.85M | 51.25%-51.78M | 42.09%-228.42M | 76.51%-22.46M | 56.72%-33.35M |
| Net income from continuing operations | 98.75%-1.64M | 67.86%-41.53M | -24.90%-604.14M | -133.96%-221.5M | 47.07%-121.9M | 11.21%-131.55M | -1,122.36%-129.19M | 84.30%-483.68M | 83.90%-94.68M | -1.51%-230.28M |
| Operating gains losses | -133.51%-22.62M | -87.41%10.05M | 157.63%413.41M | 778.32%189.82M | -47.02%76.3M | -40.21%67.5M | 216.56%79.79M | -54.65%160.47M | -199.64%-27.98M | 53.14%144.01M |
| Depreciation and amortization | -10.30%9.25M | -12.33%9.67M | -18.91%43.12M | 1.52%11.47M | -15.74%10.31M | -17.74%10.31M | -35.54%11.03M | -33.56%53.18M | -41.48%11.3M | -36.61%12.24M |
| Asset impairment expenditure | -98.38%303K | 26.74%109K | -62.29%20.29M | -97.59%1.31M | -99.19%203K | 151.09%18.68M | -99.19%86K | -97.52%53.8M | -85.35%54.61M | 78.89%25.17M |
| Unrealized gains and losses of investment securities | ---- | ---- | ---- | ---- | -47.02%76.3M | -40.21%67.5M | 216.56%79.79M | -54.65%160.47M | -199.64%-27.98M | 53.14%144.01M |
| Remuneration paid in stock | -61.52%2.01M | -102.38%-99K | -129.65%-4.21M | -562.27%-18.74M | 39.70%5.16M | 92.16%5.22M | 11.68%4.15M | -44.00%14.18M | -8.49%4.05M | -39.01%3.69M |
| Deferred tax | -29.14%214K | -95.30%291K | -42.07%7.14M | 122.93%329K | 129.34%316K | -97.64%302K | 206.94%6.19M | 315.21%12.33M | 91.23%-1.44M | 19.39%-1.08M |
| Other non cashItems | -281.74%-3.91M | 125.43%2.9M | 77.97%-9.4M | -54.43%2.39M | -86.94%642K | 96.34%-1.02M | 54.08%-11.41M | -1,524.17%-42.65M | -68.19%5.25M | -69.54%4.92M |
| Change In working capital | 93.21%-1.58M | 166.49%8.27M | -905.77%-31.97M | -93.33%1.76M | -74.97%2M | -535.03%-23.29M | 65.25%-12.44M | -93.27%3.97M | -60.95%26.43M | 426.20%7.97M |
| -Change in receivables | 596.84%22.47M | 336.38%2.92M | -19.63%-4.49M | -112.34%-1.32M | -353.11%-7.06M | -57.05%3.22M | 103.27%668K | -160.06%-3.75M | 255.21%10.71M | -249.28%-1.56M |
| -Change in inventory | -61.00%-7.99M | 140.50%2.84M | -1,813.25%-17.72M | -152.76%-4.79M | 74.99%-952K | 23.36%-4.96M | -413.28%-7.01M | -98.49%1.03M | -86.75%9.08M | -53.20%-3.81M |
| -Change in prepaid assets | 47.42%-2.87M | -1,342.16%-2.67M | 335.06%5.72M | 500.00%6.36M | 943.51%5M | -734.56%-5.46M | -145.79%-185K | -119.42%-2.43M | -110.46%-1.59M | -106.90%-593K |
| -Change in payables and accrued expense | 18.04%-13.19M | 187.70%5.18M | -269.87%-15.48M | -81.57%1.52M | -64.10%5M | -423.27%-16.09M | 67.19%-5.91M | 132.28%9.12M | 189.82%8.22M | 347.10%13.93M |
| Cash from discontinued investing activities | 0 | 0 | 0 | 0 | 0 | 67.18%-53.53M | 100.91%401K | 101.17%779K | ||
| Operating cash flow | 66.61%-17.98M | 80.04%-10.34M | 41.21%-165.75M | -50.29%-33.15M | 17.20%-26.97M | 31.53%-53.85M | 65.17%-51.78M | 49.43%-281.95M | 84.21%-22.06M | 77.37%-32.57M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 853.22%16.73M | 98.37%-705K | -128.19%-61.92M | -111.51%-1.71M | 2.24%-14.79M | -102.87%-2.22M | -130.33%-43.19M | -51.99%219.6M | -83.70%14.89M | -109.51%-15.13M |
| Net PPE purchase and sale | 52.50%-1.23M | -229.32%-1.3M | -103.90%-5.88M | -6,278.00%-3.09M | -257.38%-1.22M | -103.77%-2.58M | -98.76%1.01M | 3,250.46%150.6M | 122.42%50K | 143.91%772K |
| Net intangibles purchas and sale | ---237K | -1,207.14%-183K | 14.63%-467K | -134.32%-58K | -554.02%-395K | --0 | 95.39%-14K | 59.09%-547K | 334.72%169K | 126.61%87K |
| Net business purchase and sale | --0 | --0 | -629.63%-6.97M | --0 | --0 | --0 | ---6.97M | -106.40%-955K | 10.56%2.76M | ---3.72M |
| Net investment purchase and sale | 10,771.60%17.61M | 101.19%779K | -200.90%-78.91M | -105.03%-522K | -4.03%-13.23M | -98.17%162K | -191.12%-65.31M | -82.04%78.2M | -88.11%10.38M | -107.65%-12.72M |
| Net other investing changes | ---- | ---- | 493.35%30.31M | 27.86%1.96M | -88.84%50K | -60.55%200K | 375.82%28.1M | -297.56%-7.71M | -17.31%1.53M | 108.80%448K |
| Cash from discontinued investing activities | 0 | 0 | -35.76%14.13M | -97.10%713K | 0 | 118.81%3.26M | 5,274.07%10.16M | 191.44%21.99M | 23,975.73%24.59M | 160.64%14.52M |
| Investing cash flow | 1,514.77%16.73M | 97.87%-705K | -119.78%-47.79M | -102.54%-1M | -2,321.28%-14.79M | -98.28%1.04M | -123.17%-33.03M | -44.25%241.59M | -56.73%39.48M | -100.45%-611K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 90.01%169M | -75.93%25.46M | 131.97%148.66M | -288.43%-15.96M | 54.55%-30.1M | 132.44%88.94M | 179.46%105.78M | -2,261.40%-465.06M | -93.29%8.47M | 50.40%-66.23M |
| Net issuance payments of debt | -4,192.72%-70.74M | -101.62%-916K | 56.69%-220.78M | -374.03%-140.78M | -107.67%-134.77M | 99.44%-1.65M | 147.70%56.42M | -3,102.06%-509.78M | -122.01%-29.7M | 44.78%-64.9M |
| Net common stock issuance | 187.46%243.26M | -28.95%38.26M | 375.42%385.39M | 173.76%129.4M | --117.51M | 150.40%84.62M | --53.85M | 7,627.65%81.06M | 24,391.19%47.27M | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | --8.57M | --0 | --0 | ---- | ---- | --0 | --0 | --0 |
| Net other financing activities | -35.26%-3.51M | -164.23%-11.89M | 32.52%-24.52M | 49.69%-4.58M | -865.21%-12.85M | 76.54%-2.6M | 69.68%-4.5M | 4.38%-36.34M | -2.14%-9.1M | 91.67%-1.33M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 90.01%169M | -75.93%25.46M | 131.97%148.66M | -288.43%-15.96M | 54.55%-30.1M | 132.44%88.94M | 179.46%105.78M | -2,261.40%-465.06M | -93.29%8.47M | 50.40%-66.23M |
| Net cash flow | ||||||||||
| Beginning cash position | -34.32%126.2M | -33.17%113.81M | -74.85%170.3M | 13.43%161.91M | -5.99%228.42M | -63.97%192.16M | -74.85%170.3M | -12.76%677.01M | -76.13%142.75M | -67.46%242.98M |
| Current changes in cash | 364.34%167.75M | -31.23%14.42M | 87.16%-64.88M | -293.52%-50.11M | 27.71%-71.86M | 112.34%36.13M | 115.06%20.97M | -251.32%-505.42M | -66.69%25.89M | 30.13%-99.41M |
| Effect of exchange rate changes | 2,966.42%4.11M | -327.75%-2.03M | 749.30%8.39M | 21.19%2.01M | 749.51%5.35M | -94.43%134K | 119.63%890K | -102.88%-1.29M | 46.73%1.66M | 86.94%-824K |
| End cash Position | 30.49%298.06M | -34.32%126.2M | -33.17%113.81M | -33.17%113.81M | 13.43%161.91M | -5.99%228.42M | -63.97%192.16M | -74.85%170.3M | -74.85%170.3M | -76.13%142.75M |
| Free cash from | 65.55%-19.44M | 78.77%-11.83M | 38.09%-177.03M | -63.96%-36.3M | 13.53%-28.58M | 29.31%-56.44M | 63.08%-55.71M | 49.66%-285.95M | 84.49%-22.14M | 77.38%-33.05M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.